MedTrace Logo

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

NCT02403531 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2020-06-02

No results posted yet for this study

Summary

The contribution of induction chemotherapy before definitive chemoradiotherapy is unknown. The purpose of this study was to compare the efficacy and toxicity of induction chemotherapy followed by definitive chemoradiotherapy versus no induction chemotherapy in patients with inoperable thoracic esophageal squamous cell carcinoma.

Conditions

  • Neoplasms

Interventions

DRUG

Docetaxel

Include brand names, serial numbers and code names to improve search results on the ClinicalTrials.gov web site.

DRUG

Cisplatin

Include brand names, serial numbers and code names to improve search results on the ClinicalTrials.gov web site.

RADIATION

Radiotherapy

definitive radiotherapy

Sponsors & Collaborators

  • Mian XI

    lead OTHER

Principal Investigators

  • Meng-Zhong Liu, MD · Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-01
Primary Completion
2017-09-06
Completion
2020-05-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02403531 on ClinicalTrials.gov